Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01731769|
Recruitment Status : Unknown
Verified November 2012 by Bi-Hongda, Changhai Hospital.
Recruitment status was: Not yet recruiting
First Posted : November 22, 2012
Last Update Posted : November 22, 2012
|Condition or disease||Intervention/treatment||Phase|
|Breast Neoplasms||Procedure: vacuum assisted closure in experimental arm Procedure: Axillary dissection||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||50 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Preventing Seroma Formation After Axillary Lymph Node Dissection for Breast Cancer by Early Vacuum Assisted Closure--- a Randomized Control Clinical Trial|
|Study Start Date :||January 2013|
|Estimated Primary Completion Date :||January 2013|
|Estimated Study Completion Date :||March 2013|
Active Comparator: Axillary dissection
Axillary dissection is a surgical procedure that incises (opens) the armpit (axilla or axillary) to identify, examine, or remove lymph nodes (small glands, part of the lymphatic system, which filters cellular fluids).
Procedure: Axillary dissection
Experimental: vacuum assisted closure
Vacuum assisted closure (also called vacuum therapy, vacuum sealing or topical negative pressure therapy) is a sophisticated development of a standard surgical procedure, the use of vacuum assisted drainage to remove blood or serous fluid from a wound or operation site.
Procedure: vacuum assisted closure in experimental arm
- seroma formation complication incidence [ Time Frame: within the first 30 days (plus or minus 3 days) after surgery ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01731769
|Contact: Hongda Bi, Ph.Demail@example.com|
|Changhai Hospital||Not yet recruiting|
|Shanghai, Shanghai, China, 200433|
|Contact: Hongda Bi, Ph.D firstname.lastname@example.org|